Original Article

Additional Experience with Dexmedetomidine in Pediatric Patients

Authors: Joseph D. Tobias, MD, John W. Berkenbosch, MD, Pierantonio Russo, MD

Abstract

Purpose This study evaluates the efficacy of dexmedetomidine in clinical scenarios other than sedation during mechanical ventilation. Methods We conducted a retrospective chart review and presentation of case series of children in the pediatric intensive care unit and the postanesthesia care unit who received dexmedetomidine. Results Dexmedetomidine was administered by continuous infusion to three patients and as a single bolus dose (0.5 &mgr;g/kg) to two patients. In the five clinical scenarios, dexmedetomidine provided effective sedation during spontaneous ventilation in two patients, reversed the clinical signs and symptoms of withdrawal from illicit substances in one patient, and was effective in the treatment of postanesthesia emergence delirium and shivering in two additional patients. Conclusion These preliminary data suggest that dexmedetomidine may be an effective agent for sedation in spontaneously breathing patients, in the treatment of drug withdrawal, and in the treatment of two common postanesthesia problems.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90: 699–705.
 
2. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers: Part 1. Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83: 372–380.
 
3. Peden CJ, Cloote AH, Stratford N, et al. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 2001; 56: 408–413.
 
4. Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 2000; 90: 834–839.
 
5. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136–1142.
 
6. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12: 171–175.
 
7. Dupeyrat A, Goujard E, Muret J, et al. Transcutaneous CO2 tension effects of clonidine in paediatric caudal analgesia. Paediatr Anaesth 1998; 8: 145–148.
 
8. Benhamou D, Veillette Y, Narchi P, et al. Ventilatory effects of premedication with clonidine. Anesth Analg 1991; 73: 799–803.
 
9. Deutsch ES, Nadkarni VM. Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 1996; 122: 1234–1238.
 
10. Gold MS, Pottash AL, Sweeney DR, et al. Efficacy of clonidine in opiate withdrawal: A study of thirty patients. Drug Alcohol Depend 1980; 6: 201–208.
 
11. Vetulani J, Bednarczyk B. Depression by clonidine of shaking behavior elicited by nalorphine in morphine-dependent rats. J Pharm Pharmacol 1977; 29: 567–569.
 
12. Redmond DE Jr, Huang YH. The primate locus ceruleus and effects of clonidine on opiate withdrawal. Drug Alcohol Depend 1980; 6: 201–208.
 
13. Ashton H. Benzodiazepine withdrawal: Outcome in 50 patients. Br J Addict 1987; 82: 665–671.
 
14. Cushman P Jr, Sowers JR. Alcohol withdrawal syndrome: Clinical and hormonal responses to α2-adrenergic treatment. Alcoholism 1989; 13: 361–364.
 
15. Glassman AH, Jackson WK, Walsh BT, et al. Cigarette craving, smoking withdrawal, and clonidine. Science 1984; 226: 864–866.
 
16. Cole JW, Murray DJ, McAllister JD, et al. Emergence behaviour in children: Defining the incidence of excitement and agitation following anaesthesia. Paediatr Anaesth 2002; 12: 442–447.
 
17. Bock M, Kunz P, Schreckenberger R, et al. Comparison of caudal and intravenous clonidine in the prevention of agitation after sevoflurane in children. Br J Anaesth 2002; 88: 790–796.
 
18. Kulka PJ, Bressem M, Tryba M. Clonidine prevents sevoflurane-induced agitation in children. Anesth Analg 2001; 93: 335–338.
 
19. Kranke P, Eberhart LH, Roewer N, et al. Pharmacological treatment of postoperative shivering: A quantitative systematic review of randomized controlled trials. Anesth Analg 2002; 94: 453–460.
 
20. Schwarzkopf KR, Hoff H, Hartmann M, et al. A comparison between meperidine, clonidine and urapidil in the treatment of postanesthetic shivering. Anesth Analg 2001; 92: 257–260.
 
21. Berkenbosch JW, Tobias JD. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003; 4: 203–205.